Focusing on Accountability, CTSI Expands Board

CTSI director Clay Johnston (left) with David Vlahov, dean of the UCSF School of Nursing and one of five new CTSI board members.
March 12, 2012

The Clinical and Translational Science Institute (CTSI) at UCSF has announced an expansion of its current board to more fully reflect the campus-wide community that it serves. New board members include deans from the Schools of Dentistry, Nursing, and Pharmacy, as well as other key campus leaders.

“This expansion further ensures that CTSI is fully integrated with the larger campus,” said Clay Johnston, MD, PhD, director of CTSI and associate vice chancellor of research at UCSF. “And it makes us more accountable. Since CTSI’s efforts to accelerate translational research touch all sectors of the UCSF campus, we want the campus broadly represented at the table.”

New board members include:

Existing board members including Deborah Grady, MD, associate dean of clinical and translational research, serve as representatives of the the UCSF School of Medicine. View the entire CTSI board of directors here.

This expansion further ensures that CTSI is fully integrated with the larger campus.
Clay Johnston, MD, PhD

“This move also parallels CTSI’s expansion of activities,” Johnston said. “We are always looking for opportunities to better meet the needs of faculty and staff, and this will help to do that by improving communication and collaboration with partners across campus.”

Under the banner of Accelerating Research to Improve Health, CTSI is a campus-wide Institute that supports all four UCSF schools and researchers at every stage. View a video to learn more.

The Institute is a member of the National Institutes of Health-funded Clinical and Translational Science Awards network. It provides a wide range of services for researchers, and promotes online collaboration and networking through UCSF Profiles.